4//SEC Filing
SAMSON MARVIN 4
Accession 0001209191-19-061964
CIK 0001016169other
Filed
Dec 25, 7:00 PM ET
Accepted
Dec 26, 4:57 PM ET
Size
8.6 KB
Accession
0001209191-19-061964
Insider Transaction Report
Form 4
SAMSON MARVIN
Director
Transactions
- Exercise/Conversion
Common Stock
2019-12-23$1.12/sh+150,000$168,000→ 201,751 total - Sale
Common Stock
2019-12-23$4.71/sh−150,000$706,500→ 51,751 total - Exercise/Conversion
Stock Option (right to buy)
2019-12-23−150,000→ 0 totalExercise: $1.12From: 2016-06-02Exp: 2026-06-01→ Common Stock (150,000 underlying)
Footnotes (1)
- [F1]The stock option exercise and sale of common stock reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan.
Documents
Issuer
ANTARES PHARMA, INC.
CIK 0001016169
Entity typeother
Related Parties
1- filerCIK 0000901056
Filing Metadata
- Form type
- 4
- Filed
- Dec 25, 7:00 PM ET
- Accepted
- Dec 26, 4:57 PM ET
- Size
- 8.6 KB